Louisiana State Employees Retirement System Regeneron Pharmaceuticals, Inc. Transaction History

Louisiana State Employees Retirement System

$5.33 Billion
Q3 2024

A detailed history of Louisiana State Employees Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 14,300 shares of REGN stock, worth $10.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

14,300

Previous 14,600 2.05%

Holding current value

$10.2 Million

Previous $15.3 Million 2.04%

% of portfolio

0.28%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$1024.09 - $1201.76 $307,227 - $360,528	-300 Reduced 2.05%	14,300 $15 Million
Q1 2024 Apr 23, 2024	SELL	$902.69 - $993.35 $361,076 - $397,340	-400 Reduced 2.67%	14,600 $14.1 Million
Q3 2023 Oct 17, 2023	BUY	$692.45 - $844.37 $1.11 Million - $1.35 Million	1,600 Added 11.94%	15,000 $12.3 Million
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $700,030 - $830,350	1,000 Added 8.06%	13,400 $9.63 Million
Q1 2023 Apr 19, 2023	BUY	$680.49 - $826.97 $136,098 - $165,394	200 Added 1.64%	12,400 $10.2 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $352,945 - $383,195	-500 Reduced 3.94%	12,200 $8.8 Million
Q3 2022 Oct 19, 2022	BUY	$573.97 - $724.32 $57,397 - $72,432	100 Added 0.79%	12,700 $8.75 Million
Q2 2022 Jul 20, 2022	BUY	$548.35 - $738.84 $109,670 - $147,768	200 Added 1.61%	12,600 $7.51 Million
Q1 2022 Apr 22, 2022	BUY	$595.12 - $698.43 $119,024 - $139,686	200 Added 1.64%	12,400 $8.92 Million
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $163,044 - $201,291	300 Added 2.52%	12,200 $7.71 Million
Q1 2021 Apr 14, 2021	BUY	$446.73 - $548.2 $357,384 - $438,560	800 Added 7.21%	11,900 $5.63 Million
Q4 2020 Jan 11, 2021	BUY	$478.3 - $607.98 $2.77 Million - $3.53 Million	5,800 Added 109.43%	11,100 $5.36 Million
Q3 2020 Oct 19, 2020	BUY	$544.75 - $658.21 $544,750 - $658,210	1,000 Added 23.26%	5,300 $2.97 Million
Q2 2020 Jul 13, 2020	BUY	$493.32 - $643.92 $443,988 - $579,528	900 Added 26.47%	4,300 $2.68 Million
Q1 2020 Apr 13, 2020	SELL	$336.18 - $494.43 $134,472 - $197,772	-400 Reduced 10.53%	3,400 $1.66 Million
Q3 2019 Oct 24, 2019	SELL	$273.46 - $318.39 $27,345 - $31,839	-100 Reduced 2.56%	3,800 $1.05 Million
Q2 2019 Jul 15, 2019	SELL	$299.6 - $414.82 $59,920 - $82,964	-200 Reduced 4.88%	3,900 $1.14 Million
Q4 2018 Jan 14, 2019	SELL	$335.82 - $403.04 $134,328 - $161,216	-400 Reduced 8.89%	4,100 $1.53 Million
Q3 2018 Oct 16, 2018	SELL	$351.14 - $408.51 $35,114 - $40,851	-100 Reduced 2.17%	4,500 $1.82 Million
Q2 2018 Jul 18, 2018	SELL	$284.6 - $344.99 $28,460 - $34,499	-100 Reduced 2.13%	4,600 $1.59 Million
Q4 2017 Jan 16, 2018	SELL	$358.63 - $469.95 $35,863 - $46,995	-100 Reduced 2.08%	4,700 $1.77 Million
Q3 2017 Oct 16, 2017	BUY	$431.38 - $504.0 $2.07 Million - $2.42 Million	4,800	4,800 $2.15 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Regeneron Pharmaceuticals, Inc. Transaction History